Drug Fails to Show Significant Improvement in Depression Metrics
The drug did not achieve statistically significant results on MADRS and SHAPS scales, highlighting the challenges in depression treatment efficacy.
The drug did not show statistically significant improvement in the MADRS total score or SHAPS scale.